These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25161160)

  • 41. Pharmacokinetics and dose proportionality of extended-release metformin following administration of 1000, 1500, 2000 and 2500 mg in healthy volunteers.
    Cullen E; Liao J; Lukacsko P; Niecestro R; Friedhoff L
    Biopharm Drug Dispos; 2004 Sep; 25(6):261-3. PubMed ID: 15334625
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of changeover from voglibose to acarbose on postprandial triglycerides in type 2 diabetes mellitus patients.
    Matsumura M; Monden T; Miyashita Y; Kawagoe Y; Shimizu H; Nakatani Y; Domeki N; Yanagi K; Ikeda S; Kasai K
    Adv Ther; 2009 Jun; 26(6):660-6. PubMed ID: 19568704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigation of the pharmacokinetic and pharmacodynamic interactions between memantine and glyburide/metformin in healthy young subjects: a single-center, multiple-dose, open-label study.
    Rao N; Chou T; Ventura D; Abramowitz W
    Clin Ther; 2005 Oct; 27(10):1596-606. PubMed ID: 16330295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential interactions between cilostazol and probucol: a two-part, single-dose, open-label study in healthy Korean male volunteers.
    Kim KP; Kim BH; Lim KS; Kim TE; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Oct; 31(10):2098-106. PubMed ID: 19922880
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of concomitant administration of trospium chloride extended release on the steady-state pharmacokinetics of metformin in healthy adults.
    Oefelein MG; Tong W; Kerr S; Bhasi K; Patel RK; Yu D
    Clin Drug Investig; 2013 Feb; 33(2):123-31. PubMed ID: 23325481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of the ingestion of Ginkgo biloba extract (EGb 761) on the pharmacokinetics of metformin in non-diabetic and type 2 diabetic subjects--a double blind placebo-controlled, crossover study.
    Kudolo GB; Wang W; Javors M; Blodgett J
    Clin Nutr; 2006 Aug; 25(4):606-16. PubMed ID: 16698134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The pharmacokinetics and safety of a fixed-dose combination of acetylsalicylic acid and clopidogrel compared with the concurrent administration of acetylsalicylic acid and clopidogrel in healthy subjects: a randomized, open-label, 2-sequence, 2-period, single-dose crossover study.
    Jung JA; Kim TE; Kim JR; Kim MJ; Huh W; Park KM; Lee SY; Ko JW
    Clin Ther; 2013 Jul; 35(7):985-94. PubMed ID: 23870608
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Linagliptin monotherapy provides superior glycaemic control versus placebo or voglibose with comparable safety in Japanese patients with type 2 diabetes: a randomized, placebo and active comparator-controlled, double-blind study.
    Kawamori R; Inagaki N; Araki E; Watada H; Hayashi N; Horie Y; Sarashina A; Gong Y; von Eynatten M; Woerle HJ; Dugi KA
    Diabetes Obes Metab; 2012 Apr; 14(4):348-57. PubMed ID: 22145698
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of extended-release versus conventional tramadol/acetaminophen fixed-dose combination tablets: an open-label, 2-treatment, multiple-dose, randomized-sequence crossover study in healthy korean male volunteers.
    Yi S; Chung YJ; Kim TE; Shin HS; Yoon SH; Cho JY; Jang IJ; Shin SG; Yu KS
    Clin Ther; 2011 Jun; 33(6):728-37. PubMed ID: 21704237
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
    Ahmad M; Pervaiz F
    Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetic interaction between pitavastatin and valsartan: a randomized, open-labeled crossover study in healthy male Korean volunteers.
    Jung JA; Noh YH; Jin S; Kim MJ; Kim YH; Jung JA; Lim HS; Bae KS
    Clin Ther; 2012 Apr; 34(4):958-65. PubMed ID: 22410289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized, open-label, crossover study to evaluate the pharmacokinetics of empagliflozin and linagliptin after coadministration in healthy male volunteers.
    Friedrich C; Metzmann K; Rose P; Mattheus M; Pinnetti S; Woerle HJ
    Clin Ther; 2013 Jan; 35(1):A33-42. PubMed ID: 23328275
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of a nonsystemic, orally administered hydrogel, GS100, on metformin pharmacokinetics.
    Urban LE; Audet D; Ron ES; Sannino A; Zohar Y; Demitri C; Panteca E; Surano I; Heshmati HM
    Can J Physiol Pharmacol; 2018 Nov; 96(11):1127-1131. PubMed ID: 30067074
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Linagliptin fixed-dose combination with metformin is bioequivalent to co-administration of linagliptin and metformin as individual tablets.
    Buschke S; Ring A; Friedrich C; Metzmann K; Meinicke T
    Int J Clin Pharmacol Ther; 2014 Jul; 52(7):537-48. PubMed ID: 24755123
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of cephalexin on the pharmacokinetics of metformin in healthy human volunteers.
    Jayasagar G; Krishna Kumar M; Chandrasekhar K; Madhusudan Rao C; Madhusudan Rao Y
    Drug Metabol Drug Interact; 2002; 19(1):41-8. PubMed ID: 12222753
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Effect of Nizatidine, a MATE2K Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin in Healthy Volunteers.
    Morrissey KM; Stocker SL; Chen EC; Castro RA; Brett CM; Giacomini KM
    Clin Pharmacokinet; 2016 Apr; 55(4):495-506. PubMed ID: 26507723
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Voglibose has no effect on the pharmacokinetics of hydrochlorothiazide.
    Kleist P; Suzuki Y; Thomsen T; Möller M; Römer A; Hucke HP; Kurowski M; Eckl KM
    Eur J Clin Pharmacol; 1998 May; 54(3):273-4. PubMed ID: 9681672
    [No Abstract]   [Full Text] [Related]  

  • 60. The influence of telmisartan on metformin pharmacokinetics and pharmacodynamics.
    Wen J; Zeng M; Liu Z; Zhou H; Xu H; Huang M; Zhang W
    J Pharmacol Sci; 2019 Jan; 139(1):37-41. PubMed ID: 30538075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.